YPSOMED HLDG (Switzerland) Today

Equity ratings for YPSOMED HLDG are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of December 2020 and ending today, the 28th of July 2021. Click here to learn more.
YPSOMED HLDG cannot be verified against its exchange. It looks like YPSOMED HLDG is not available for investing at the moment. Please verify the symbol is currently traded on Switzerland Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

YPSOMED HLDG Stock Profile

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland. YPSOMED HLDG operates under Medical Devices classification in Switzerland and is traded on Switzerland Exchange. It employs 1522 people.. The public information regarding YPSOMED HLDG's current market price is not available at this time.
YPSOMED HLDG is not yet fully synchronised with the market data
YPSOMED HLDG has some characteristics of a very speculative penny stock
The company has accumulated 122 M in total debt with debt to equity ratio (D/E) of 32.2, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. YPSOMED HLDG has a current ratio of 0.93, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
Legal NameYPSOMED HLDG
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of YPSOMED HLDG's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
YPSOMED HLDG (YPSN) is traded on Switzerland Exchange in Switzerland and employs 1,522 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.65 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate YPSOMED HLDG's market, we take the total number of its shares issued and multiply it by YPSOMED HLDG's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. YPSOMED HLDG operates under null sector and is part of null industry. The entity has 12.6 M outstanding shares. YPSOMED HLDG has accumulated about 12.08 M in cash with 59.86 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96.
Check YPSOMED HLDG Probability Of Bankruptcy

YPSOMED Stock Against Markets

Picking the right benchmark for YPSOMED HLDG stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in YPSOMED HLDG stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for YPSOMED HLDG is critical whether you are bullish or bearish towards YPSOMED HLDG at a given time.
YPSOMED HLDG cannot be verified against its exchange. It looks like YPSOMED HLDG is not available for investing at the moment. Please verify the symbol is currently traded on Switzerland Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with YPSOMED HLDG stock to make a market-neutral strategy. Peer analysis of YPSOMED HLDG could also be used in its relative valuation, which is a method of valuing YPSOMED HLDG by comparing valuation metrics with similar companies.
Check out Your Current Watchlist. Note that the YPSOMED HLDG information on this page should be used as a complementary analysis to other YPSOMED HLDG's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Tools for YPSOMED Stock

When running YPSOMED HLDG price analysis, check to measure YPSOMED HLDG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy YPSOMED HLDG is operating at the current time. Most of YPSOMED HLDG's value examination focuses on studying past and present price action to predict the probability of YPSOMED HLDG's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move YPSOMED HLDG's price. Additionally, you may evaluate how the addition of YPSOMED HLDG to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go